From Name

From Email

To Name

To Email

Message

The strategy, tactics, and process behind successful seamless and adaptively designed clinical trials

from Life Science Leader

The strategy, tactics, and process behind successful seamless and adaptively designed clinical trials Life Science Leader After months of planning — and working with the FDA — Galectin Therapeutics recently launched a seamless and adaptive design Phase 2b/3 clinical trial of belapectin in patients with nonalcoholic steatohepatitis (NASH) cirrhosis. For those accustomed to just one type of clinical trial, you may ask, what is a seamless and adaptively designed clinical trial? So, here are some of the key takeaways we've learned in the process. READ MORE

more